Distinct CCK-2 Receptor Conformations Associated with β-Arrestin-2 Recruitment or Phospholipase-C Activation Revealed by a Biased Antagonist-Reference-Cited by-同舟云学术

Distinct CCK-2 Receptor Conformations Associated with β-Arrestin-2 Recruitment or Phospholipase-C Activation Revealed by a Biased Antagonist

Published:2013-02-06 Issue:7 Volume:135 Page:2560-2573
ISSN:0002-7863
Container-title:Journal of the American Chemical Society
language:en
Short-container-title:J. Am. Chem. Soc.

Author:

Magnan Rémi¹,Escrieut Chantal¹,Gigoux Véronique¹,De Kavita¹,Clerc Pascal¹,Niu Fan¹,Azema Joelle²³,Masri Bernard⁴³,Cordomi Arnau¹,Baltas Michel²³,Tikhonova Irina G.⁵,Fourmy Daniel¹

Affiliation:

1. EA 4552, Université de Toulouse 3, 31432 Toulouse, France

2. CNRS, LSPCMIB, UMR-5068, Toulouse, France

3. Université de Toulouse 3, Toulouse, France

4. INSERM U1037, Cancer Research Center of Toulouse, Toulouse, France

5. School of Pharmacy, Queen’s University Belfast, Belfast BT9 7BL, United Kingdom

Publisher

American Chemical Society (ACS)

Subject

Colloid and Surface Chemistry,Biochemistry,General Chemistry,Catalysis

Link

https://pubs.acs.org/doi/pdf/10.1021/ja308784w

Reference66 articles.

1. The druggable genome

2. Teaching old receptors new tricks: biasing seven-transmembrane receptors

3. Transduction of Receptor Signals by ß-Arrestins

4. Beta-arrestins as regulators of signal termination and transduction: How do they determine what to scaffold?

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Validation of Novel Z-360-Based Macromolecules for the Active Targeting of CCK2-R;Molecular Pharmaceutics;2024-07-03

2. Precision peptide theranostics: developing N- to C-terminus optimized theranostics targeting cholecystokinin-2 receptor;Theranostics;2024

3. A Novel CCK Receptor GPR173 Mediates Potentiation of GABAergic Inhibition;The Journal of Neuroscience;2023-02-22

4. Elucidating the molecular determinants in the process of gastrin C-terminal pentapeptide amide end activating cholecystokinin 2 receptor by Gaussian accelerated molecular dynamics simulations;Frontiers in Pharmacology;2023-01-23

5. GPCR Signaling from Intracellular Membranes;GPCRs as Therapeutic Targets;2022-09-16